Clinical Trials

Overview

About this study

The purpose of this study is to perform a paired comparison of CD34+ cell and lymphocyte yield, as well as cross-cellular contamination, on the same patient/donor using the 85 ml/min high flow rates versus the standard speeds of 65 ml/min for pre WBC of > 35 x109/L or 90 ml/min for pre WBC of ≤ 35 x109/L.  Quantities of CD34+cells, lymphocytes, white blood cells, red blood cells, and platelets in the products would be compared.  In addition, collection efficiency of CD34+ cells and lymphocytes would be compared.  The yields and collection efficiencies would be used to judge the effect of the high flow rates.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Participating Mayo Clinic locations

More information